General
publicado em 13/05/2013 às 19h30:00
   Dê o seu voto:

ANVISA opens public consultation on Chinese medicine products

The goal is to determine how will the regulation of products, which are absent from the Brazilian Health Regulations

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



The National Agency for Sanitary Surveillance (ANVISA) has approved the opening of the public consultation on the regulations for products of traditional medicine of China. The goal is to determine how it will regulate products that are currently absent from the Brazilian Health Regulations.

The text of the proposal will be published in the Official Gazette in the coming days. After publication, will be 90 days to submit comments and suggestions. The consultation aims to enable the monitoring of possible effects related to the use of these products. Today there is no formula that blends traditional Chinese minerals, plants and animals with registration in Brazil.

According to CEO of ANVISA, Dirceu Barbano, products have specific characteristics that are not included in any health regulations existing in Brazil. The multifactorial composition of traditional products in China requires a differentiated analysis of health assessment, informs Barbano.

The proposal states that Chinese products will not require registration with ANVISA. The text prohibits the appointment of therapeutic claim on product labels and in promotional material. The manufacture must also follow the rules of the Chinese Pharmacopoeia, being forbidden the inclusion of raw materials of animal origin. Another proposal restricts the prescription product to qualified professionals.

Source: AGÊNCIA BRASIL
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: ANVISA opens public consultation on Chinese medicine products
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: ANVISA opens public consultation on Chinese medicine products


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
Chinese medicine products    the National Agency for Sanitary Vigilance    products of traditional medicine in China    Brazilian Health Regulations    standards of Chinese Pharmacopoeia    Dirceu Barbano   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.